Imprimatur Capital

Imprimatur Capital is a venture capital firm with a strong focus on early-stage technology startups in the Baltic Sea region. Established in 2003, the firm has carved out a niche in sectors like B2B software, digital health, robotics, and automation. With a global perspective, Imprimatur helps startups with scalable business models reach international markets. The firm typically invests between €200k and €2 million in companies that have demonstrated initial revenue, particularly those with a minimum of €5,000 MRR. Imprimatur’s team operates from offices in Riga, London, and Singapore, bringing deep expertise in engineering, life sciences, entrepreneurship, and finance to the table. This diverse skill set enables the firm to provide more than just capital; they offer strategic guidance to ensure startups achieve sustainable growth. Imprimatur’s investment strategy is built on identifying ambitious founders with innovative solutions that address significant market needs. Their portfolio includes over 70 startups, such as Anatomy Next, which has successfully scaled with their support. Although their current fund is fully invested, Imprimatur continues to maintain a strong presence in the venture capital ecosystem, focusing on driving technological advancements that have the potential to impact industries globally. Their commitment to fostering innovation is evident in their active involvement in the startups they back, providing long-term support that goes beyond initial funding to include mentorship, market access, and business development expertise.